MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings

Not Applicable
Completed
Conditions
HIV/AIDS
Tuberculosis
Hepatitis
Addiction
Opioid Dependence
Interventions
First Posted Date
2017-03-24
Last Posted Date
2024-10-04
Lead Sponsor
Yale University
Target Recruit Count
1702
Registration Number
NCT03089983
Locations
🇲🇾

Kajang Prison, Kajang, Selangor, Malaysia

Electronic Cigarette Use in Young Adult Men and Women

Not Applicable
Completed
Conditions
Cigarette Smoking
Tobacco Use
Interventions
Behavioral: Survey Arm
First Posted Date
2017-03-24
Last Posted Date
2023-05-03
Lead Sponsor
Yale University
Target Recruit Count
29
Registration Number
NCT03089541
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Financial Incentives, Randomization With Stepped Treatment Trial

Not Applicable
Completed
Conditions
Unhealthy Alcohol Use
Interventions
Behavioral: Contingency Management Counseling
Behavioral: Addiction Physician Management
Behavioral: Motivational Enhancement Therapy
First Posted Date
2017-03-24
Last Posted Date
2024-04-15
Lead Sponsor
Yale University
Target Recruit Count
120
Registration Number
NCT03089320
Locations
🇺🇸

Greater Los Angeles VA Healthcare Center Infectious Disease Section, Los Angeles, California, United States

🇺🇸

James J. Peters VA Medical Center, Bronx, New York, United States

🇺🇸

VA Medical Center, Atlanta, Georgia, United States

and more 4 locations

Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI

Phase 1
Active, not recruiting
Conditions
Stroke
Intracranial Atherosclerosis
Interventions
First Posted Date
2017-03-21
Last Posted Date
2025-01-22
Lead Sponsor
Yale University
Target Recruit Count
80
Registration Number
NCT03084523
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Novel Device for Rapid Fluid Administration

Not Applicable
Completed
Conditions
Device Related Sepsis
Interventions
Device: Pressure Bag
Device: Lifeflow
Device: Push/Pull
First Posted Date
2017-03-09
Last Posted Date
2019-01-31
Lead Sponsor
Yale University
Target Recruit Count
54
Registration Number
NCT03074682
Locations
🇺🇸

Departments of Pediatrics and Emergency Medicine, Yale University, New Haven, Connecticut, United States

Impact of Switching to Non-Menthol Cigarettes Among Smokers

Not Applicable
Completed
Conditions
Tobacco Use
Interventions
Other: Cigarette Brand Switching
First Posted Date
2017-03-09
Last Posted Date
2023-03-02
Lead Sponsor
Yale University
Target Recruit Count
33
Registration Number
NCT03075839
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome

Phase 2
Completed
Conditions
Tourette Syndrome
Interventions
First Posted Date
2017-02-28
Last Posted Date
2020-02-24
Lead Sponsor
Yale University
Target Recruit Count
17
Registration Number
NCT03066193
Locations
🇺🇸

Yale Child Study Center, New Haven, Connecticut, United States

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment

Phase 2
Completed
Conditions
Binge-Eating Disorder
Obesity
Interventions
Behavioral: Cognitive-Behavioral Therapy (CBT)
First Posted Date
2017-02-24
Last Posted Date
2024-02-01
Lead Sponsor
Yale University
Target Recruit Count
31
Registration Number
NCT03063606
Locations
🇺🇸

Yale School of Medicine, New Haven, Connecticut, United States

Self- and Family-management Intervention in HIV+ Chinese Women

Not Applicable
Completed
Conditions
Hiv
Interventions
Behavioral: self- and family-management intervention sessions
First Posted Date
2017-02-10
Last Posted Date
2017-02-10
Lead Sponsor
Yale University
Target Recruit Count
82
Registration Number
NCT03049332
Locations
🇨🇳

Beijing Ditan Hospital, Beijing, China

🇨🇳

Shanghai Public Health Clinical Center, Shanghai, China

Optimizing Acquisition Parameters and Interpretive Methods of FDG-PET/CT With Rb-82

Early Phase 1
Completed
Conditions
Sarcoidosis
Interventions
Drug: Fluorodeoxyglucose
Diagnostic Test: FDG-PET/CT with Rb82 Myocardial Perfusion Imaging
First Posted Date
2017-02-09
Last Posted Date
2019-08-26
Lead Sponsor
Yale University
Target Recruit Count
15
Registration Number
NCT03048097
Locations
🇺🇸

Yale New Haven Hospital, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath